Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Michael Nerenberg"'
Autor:
Jiali Zhuang, Arkaitz Ibarra, Alexander Acosta, Amy P. Karns, Jonathan Aballi, Michael Nerenberg, John J. Sninsky, Stephen R. Quake, Shusuke Toden
Publikováno v:
EBioMedicine, Vol 83, Iss , Pp 104242- (2022)
Summary: Background: Inflammatory and immune responses are essential and dynamic biological processes that protect the body against acute and chronic adverse stimuli. While conventional protein markers have been used to evaluate systemic inflammatory
Externí odkaz:
https://doaj.org/article/118efc30942c4675a48ce58d03e97097
Autor:
Arkaitz Ibarra, Jiali Zhuang, Yue Zhao, Neeraj S. Salathia, Vera Huang, Alexander D. Acosta, Jonathan Aballi, Shusuke Toden, Amy P. Karns, Intan Purnajo, Julianna R. Parks, Lucy Guo, James Mason, Darren Sigal, Tina S. Nova, Stephen R. Quake, Michael Nerenberg
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
Circulating cell-free mRNA holds great promise as a non-invasive diagnostic biomarker. Here the authors show that cell-free mRNA captures transcripts from the bone marrow and can be used to non-invasively monitor dynamic changes in bone marrow physio
Externí odkaz:
https://doaj.org/article/87196fe47ad34f7e87daf12fccf54685
Autor:
Naga Chalasani, Raj Vuppalanchi, Craig Lammert, Samer Gawrieh, Jerome V. Braun, Jiali Zhuang, Arkaitz Ibarra, David A. Ross, Michael Nerenberg, Stephen R. Quake, John J. Sninsky, Shusuke Toden
Publikováno v:
Hepatology Communications. 7
BACKGROUND & AIMSPrimary sclerosing cholangitis (PSC) is a rare chronic cholestatic liver disease characterized by multi-focal bile duct strictures. To date, underlying molecular mechanisms of PSC remain unclear and therapeutic options for PSC patien
Autor:
Jiali Zhuang, Arkaitz Ibarra, Alexander Acosta, Amy P. Karns, Jonathan Aballi, Michael Nerenberg, Stephen R. Quake, Shusuke Toden
Inflammatory and immune responses are essential and dynamic biological processes that protect the body against acute and chronic adverse stimuli. While conventional protein markers have been used to evaluate systemic inflammatory response, the immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c9e902b333edd7bb652ad4d29cd8b21
https://doi.org/10.1101/2021.12.14.472685
https://doi.org/10.1101/2021.12.14.472685
Autor:
Arkaitz Ibarra, Yue Zhao, Neeraj S. Salathia, Jiali Zhuang, Vera Huang, Alexander D. Acosta, Jonathan Aballi, Shusuke Toden, Amy P. Karns, Intan Purnajo, Julianna R. Parks, Lucy Guo, James Mason, Darren Sigal, Tina S. Nova, Stephen R. Quake, Michael Nerenberg
Circulating cell free mRNA (cf-mRNA) holds great promise as a non-invasive diagnostic biomarker. However, the biological origin of cf-mRNA is still not well understood, limiting the clinical applications of this technology. Here, we use the bone marr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5baf9dbff3e2fe31e2c946ed73a09d4d
https://doi.org/10.1101/516666
https://doi.org/10.1101/516666
Autor:
Michael Nerenberg
Publikováno v:
BioTechniques, Vol 20, Iss 5, Pp 880-880 (1996)
Externí odkaz:
https://doaj.org/article/13dc5c6c37d342e0a85a57928d0fccec
Publikováno v:
Nucleic Acids Research. 25:776-780
Oligonucleotide N3'-->P5'phosphoramidates are a new and promising class of antisense agents. Here we report biological properties of phosphoramidate oligonucleotides targeted against the human T cell leukemia virus type-I Tax protein, the major trans
Autor:
Jonathan Diver, Michael Nerenberg, Sudipto Sur, Alan Saven, Jorge Nieva, Samuel Riccitelli, Patricia McNeeley, Ilona Kariv, Philippe J. Marchand
Publikováno v:
Leukemialymphoma. 47(10)
B-cell chronic lymphocytic leukemia [CLL] is characterized by active accumulation of clonal CD5+/CD19+/CD23+ B cells. Individualized characterization of patient cell resistance/sensitivity to specific agents can provide important information to guide
Autor:
Bryan A. Loy, George D. Demetri, Robert William Sweetman, Mara Bloom, Marc Ladanyi, Paul Papagni, Kate Murphy, Sean Tunis, Paul F. Engstrom, Jessica K. DeMartino, Mark E. Robson, Jonathan K. Larsen, Michael Nerenberg, William Goeckeler, Phillip G. Febbo
Publikováno v:
Scopus-Elsevier
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Personalized medicine in oncology is maturing and evolving rapidly, and the use of molecular biomarkers in clinical decision-making is growing. This raises important issues regarding the safe, effective, and efficient deployment of molecular tests to
Autor:
Ilona Kariv, Jorge Nieva, Jonathan Diver, Alan Saven, Philippe J. Marchand, Michael Nerenberg, Patricia McNeeley, Samuel Riccitelli
Publikováno v:
Blood. 104:4834-4834
In vitro drug resistance assays have shown efficacy in predicting response to chemotherapeutic drugs in a number of solid tumors. In chronic lymphocytic leukemia (CLL) many assays are limited by the difficulty involved in culturing these cells ex viv